Internal medicine, Endocrinology, Estrogen receptor, Cancer research and Estrogen receptor alpha are his primary areas of study. His research on Internal medicine often connects related areas such as Cell biology. His research integrates issues of Sperm, Capacitation, Cancer and Phosphorylation in his study of Endocrinology.
His work carried out in the field of Estrogen receptor brings together such families of science as Transactivation, Tamoxifen, PI3K/AKT/mTOR pathway, Signal transduction and Androgen receptor. He has included themes like Protein kinase B, Cancer cell, Peroxisome proliferator-activated receptor and Cyclin D1, Cyclin A in his Cancer research study. The Estrogen receptor alpha study combines topics in areas such as Phytoestrogens and Estrogen receptor beta.
His primary areas of study are Internal medicine, Cancer research, Endocrinology, Breast cancer and Estrogen receptor. His study explores the link between Internal medicine and topics such as Protein kinase B that cross with problems in PI3K/AKT/mTOR pathway. His work in Cancer research addresses subjects such as Cancer cell, which are connected to disciplines such as Apoptosis.
His biological study spans a wide range of topics, including Receptor and Aromatase. His Breast cancer research focuses on subjects like Adipokine, which are linked to Adiponectin and Adipose tissue. Estrogen receptor is a component of his Estrogen receptor alpha and Estrogen receptor beta studies.
Sebastiano Andò mainly investigates Cancer research, Breast cancer, Tumor microenvironment, Estrogen receptor and Cancer. His Cancer research research includes themes of Cancer cell, Aromatase, Tamoxifen, Targeted therapy and Metastasis. His Breast cancer study combines topics from a wide range of disciplines, such as Obesity, Malignancy, Microvesicles, Adiponectin and Estrogen.
His Tumor microenvironment research integrates issues from Receptor, Stroma and Leptin. As part of one scientific family, Sebastiano Andò deals mainly with the area of Estrogen receptor, narrowing it down to issues related to the Endocrine system, and often Biomarker. Endocrinology and Internal medicine are the areas that his Adipokine study falls under.
Sebastiano Andò focuses on Adipokine, Breast cancer, Cancer research, Adiponectin and Obesity. His Adipokine study combines topics in areas such as Signal transduction and Estrogen receptor. His Breast cancer study improves the overall literature in Internal medicine.
His research on Cancer research focuses in particular on Tumor microenvironment. His research in Adiponectin tackles topics such as Adipose tissue which are related to areas like Carcinogenesis, Estrogen receptor alpha, Hyperplasia and Metabolic syndrome. In his study, Endocrinology is inextricably linked to Cohort, which falls within the broad field of Insulin resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.
Marcello Maggiolini;Adele Vivacqua;Giovanna Fasanella;Anna Grazia Recchia.
Journal of Biological Chemistry (2004)
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Lidia Albanito;Antonio Madeo;Rosamaria Lappano;Adele Vivacqua.
Cancer Research (2007)
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Adele Vivacqua;Daniela Bonofiglio;Anna Grazia Recchia;Anna Maria Musti.
Molecular Endocrinology (2006)
Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line *
Stefania Catalano;Stefania Marsico;Cinzia Giordano;Loredana Mauro.
Journal of Biological Chemistry (2003)
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.
Adele Vivacqua;Daniela Bonofiglio;Lidia Albanito;Antonio Madeo.
Molecular Pharmacology (2006)
Leptin Induces, via ERK1/ERK2 Signal, Functional Activation of Estrogen Receptor α in MCF-7 Cells
Stefania Catalano;Loredana Mauro;Stefania Marsico;Cinzia Giordano.
Journal of Biological Chemistry (2004)
Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: Connecting TGF-β signaling with “Warburg-like” cancer metabolism and L-lactate production
Carmela Guido;Diana Whitaker-Menezes;Claudia Capparelli;Renee Balliet.
Cell Cycle (2012)
Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells.
Marcello Maggiolini;Daniela Bonofiglio;Stefania Marsico;Maria Luisa Panno.
Molecular Pharmacology (2001)
Differential Insulin-like Growth Factor I Receptor Signaling and Function in Estrogen Receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 Breast Cancer Cells
Monica Bartucci;Catia Morelli;Loredana Mauro;Sebastiano Ando.
Cancer Research (2001)
Estrogen Receptor (ER)α and ERβ Are Both Expressed in Human Ejaculated Spermatozoa: Evidence of Their Direct Interaction with Phosphatidylinositol-3-OH Kinase/Akt Pathway
Saveria Aquila;Diego Sisci;Mariaelena Gentile;Emilia Middea.
The Journal of Clinical Endocrinology and Metabolism (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: